Menetelmä Pseudomonas aeruginosa-infektioita vastaan vaikuttavien valmisteiden sekä immunoglobuliini-G-pitoisten, Pseudomonas aeruginosa-bakteeria vastaan vaikuttavien valmisteiden tuottamiseksi

Menetelmä Pseudomonas aeruginosa-infektioita vastaan vaikuttavien valmisteiden sekä immunoglobuliini-G-pitoisten, Pseudomonas aeruginosa-bakteeria vastaan vaikuttavien valmisteiden tuottamiseksi

Vaccines which are active against Pseudomonas aeruginosa infections and contain a single flagella(H) antigen of serotype a or a combination of a single flagella(H) antigen of serotype a with the flagella(H) antigen of serotype b. In humans, the vaccines according to the invention lead to the formati...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: ROTERING, HEINZ, DORNER, FRIEDRICH, EIBL, JOHANN
Format: Patent
Sprache:fin ; swe
Schlagworte:
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Vaccines which are active against Pseudomonas aeruginosa infections and contain a single flagella(H) antigen of serotype a or a combination of a single flagella(H) antigen of serotype a with the flagella(H) antigen of serotype b. In humans, the vaccines according to the invention lead to the formation of antibodies which act against Pseudomonas aeruginosa organisms of all combinations of partial flagella(H) antigens a0, a1, a2, a3, a4 and b, and they inhibit the motility of the organisms and induce killing by phagocytic cells of the human immune system.